Extract from the provided pathology report the following data points, seperated by semi-colons: summary cancer stage; histologic grade; ICD-10 code; ICD-O-3 code; pathologic N stage; pathologic T stage; whether the sample is of the primary tumor; the orgran of origin of the sample; and the cancer type.

Pathology report:
History of right kidney lesion,. PRE-OP DIAGNOSIS: Right kidney lesion. POST-OP DIAGNOSIS: Same. JRE: Right nephrectomy. ADDENDA: Addendum. SPECIAL PROCEDURE REPORT. MOLECULAR ANATOMIC PATHOLOGY FLUORESCENCE IN SITU HYBRIDIZATION ANALYSIS. Comment: Fluorescent in-situ hybridization (FISH) tests show monosomy of chromosome 17 in 35% of the tumor cells. This FISH profile is consistent with a diagnosis of a conventional clear cell renal cell carcinoma. Specimen type: Renal tumor. Paraffin Block. Centromere. and histology. Probe. Copy No. 1. Copy No. 2. Copy No. 3. Copy No. 4. and 4+. CEP1. 6(9.2%). 59(90.8%). CEP7. 12(20.0%). 48(80.0%). CEP17. 21(35.0%). 39(65.0%). Abnormality detected: Monosomy of chromosome 17 in 35% of the tumor cells. Interpretation guidelines: Chromosomal losses are considered significant if present in greater than 30% of cells. The loss is indeterminate if present in 20-. 30% of cases. The loss is considered artifactual if seen in less than 20% of cases. Chromosomal gains are considered significant if present in greater than 20% of cells. The gain is considered artifactual if seen. in. less than 20% of cases. Probes used: CEP1 (1p11.1q11.1), CEP7 (7p11.1q11.1), CEP17 (17p11.1q11.1). At least 25 cells are analyzed. The signal distribution for targeted foci of renal carcinoma is recorded. If the test results are not. consistent with the clinical findings, and/or diagnostic, a consultation between pathologist and treating physician is warranted. FINAL DIAGNOSIS: PART 1: KIDNEY, RIGHT, COMPLETION NEPHRECTOMY -. A. RENAL PARENCHYMA WITH NO EVIDENCE OF RESIDUAL TUMOR. B. URETER WITH URETERITIS CYSTICA. C. VASCULAR AND URETERAL MARGINS WITH NO EVIDENCE OF TUMOR. D. THE ADRENAL GLAND IS NOT SUBMITTED. PART 2: KIDNEY, RIGHT RENAL MASS, PARTIAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN NUCLEAR GRADE III/IV, 4.5 CM IN. GREATEST DIMENSION. B. THE NEOPLASM IS CONFINED WITHIN THE RENAL PAREMCHYMA, WITH NO INVASION OF THE RENAL SINUS OR. PERINEPHRIC ADIPOSE TISSUE. C. ANGIOLYMPHATIC INVASION IS NOT IDENTIFIED. D. ALL SURGICAL MARGINS ARE FREE OF TUMOR (See Part 1 above). E. PATHOLOGIC STAGE: pTNM = pT1b Nx Mx. F. NON-NEOPLASTIC KIDNEY WITH NO SIGNIFICANT PATHOLOGIC ABNORMALITY.

Extracted data:
Summary Stage: Stage I
Histologic Grade: G3
ICD-10 Code: C64.9
ICD-O-3 Code: 8310/3
Pathologic N Stage: pN0
Pathologic T Stage: pT1b
Primary Tumor: Yes
Organ of origin: Kidney
Cancer Type: Kidney Clear Cell Renal Carcinoma